ID

13007

Description

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00003436

Link

https://clinicaltrials.gov/show/NCT00003436

Keywords

  1. 1/11/16 1/11/16 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

January 11, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Leukemia NCT00003436

Eligibility Leukemia NCT00003436

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00003436
Criteria
Description

Criteria

histologically confirmed de novo or secondary acute myeloid leukemia (aml)
Description

acute myeloid leukemia

Data type

boolean

Alias
UMLS CUI [1]
C0023467
aggressive myelodysplastic syndromes (refractory anemia with excess blasts (raeb) and raeb in transformation) for which intensive aml therapy is considered appropriate
Description

myelodysplastic syndrome

Data type

boolean

Alias
UMLS CUI [1]
C3463824
acute promyelocytic leukemia (should also be entered into protocol mrc-atra)
Description

acute promyelocytic leukemia

Data type

boolean

Alias
UMLS CUI [1]
C0023487
no chronic myeloid leukemia in blast transformation
Description

CML

Data type

boolean

Alias
UMLS CUI [1]
C0023474
must be considered suitable for intensive chemotherapy
Description

intensive chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920
age: under 16
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
other: no other concurrent active malignancy
Description

malignancy

Data type

boolean

Alias
UMLS CUI [1]
C0006826
chemotherapy: no prior chemotherapy for leukemia
Description

chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920

Similar models

Eligibility Leukemia NCT00003436

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00003436
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
acute myeloid leukemia
Item
histologically confirmed de novo or secondary acute myeloid leukemia (aml)
boolean
C0023467 (UMLS CUI [1])
myelodysplastic syndrome
Item
aggressive myelodysplastic syndromes (refractory anemia with excess blasts (raeb) and raeb in transformation) for which intensive aml therapy is considered appropriate
boolean
C3463824 (UMLS CUI [1])
acute promyelocytic leukemia
Item
acute promyelocytic leukemia (should also be entered into protocol mrc-atra)
boolean
C0023487 (UMLS CUI [1])
CML
Item
no chronic myeloid leukemia in blast transformation
boolean
C0023474 (UMLS CUI [1])
intensive chemotherapy
Item
must be considered suitable for intensive chemotherapy
boolean
C0392920 (UMLS CUI [1])
age
Item
age: under 16
boolean
C0001779 (UMLS CUI [1])
malignancy
Item
other: no other concurrent active malignancy
boolean
C0006826 (UMLS CUI [1])
chemotherapy
Item
chemotherapy: no prior chemotherapy for leukemia
boolean
C0392920 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial